Skip to content
Anlon Healthcare logo

Anlon Healthcare IPO

MainboardListedPharma & Healthcare
Check allotment status
Issue price
₹91
Listing price
₹92
+1.10%
Current price
₹26.94
+196.04%
Subscribed
7.12x
Issue size
₹121.03 Cr
Listed on
3 Sep 2025

IPO timeline

  1. Opens
    26 AugTue
  2. Closes
    29 AugFri
  3. Allotment
    1 SepMon
  4. Refunds
    2 SepTue
  5. Demat credit
    2 SepTue
  6. Listing
    3 SepWed

Issue details

Price band
₹86 – ₹91 per share
Issue size
₹121.03 Cr
Fresh issue
₹121.03 Cr · 1.33 Cr shares
Offer for sale
None
Issue type
Fresh capital only
Face value
₹10 per share
Lot size
164 shares
Minimum investment
₹14,924
Listing on
BSE, NSE
Exchange code
AHCL · 544497

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)1164₹14,924
Retail (Max)132,132₹1,94,012
S-HNI (Min)142,296₹2,08,936
B-HNI (Min)6811,152₹10,14,832

Reservation

QIB
99,75,000 shares (75.00% of the Offer)
NII
19,95,000 shares (15.00% of the Offer)
Retail
13,30,000 shares (10.00% of the Offer)

Allotment status

Registrar: KFin Technologies Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on KFin Technologies
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
1 Sep 2025
Refunds initiated
2 Sep 2025
Shares credited to demat
2 Sep 2025
Listing
3 Sep 2025
Basis of allotment document

Grey market premium (GMP)

Updated 29 Aug 2025, 12:00 PM IST
Current GMP
₹2
+2.00%
Estimated listing price
₹93
Issue price ₹91
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 09 Nov 2026, 08:48 PM IST
Overall subscription
7.12x
Fully subscribed · 3,24,067 applications
  • QIB1.07x
  • NII (HNI)10.61x
  • Retail47.26x

Financials

Amounts in Rs. Crore
P/E (pre-issue)
17.67
P/E (post-issue)
23.57
EPS (₹)
3.86
RoE
40.45%
RoCE
21.93%
RoNW
25.51%
PAT Margin
17.06%
EBITDA Margin
26.88%
Debt / Equity
0.73
NAV (₹)
20.18

Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price on profit for the FY ended 31 Mar 2025.

Period ended31 Mar 202531 Mar 202431 Mar 2023
Assets181.30128.00111.55
Total Income120.4666.69113.12
Profit After Tax20.529.665.82
EBITDA32.3815.5712.66
NET Worth80.4221.037.37
Reserves and Surplus40.575.03-4.63
Total Borrowing58.3574.5666.39
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Anlon Healthcare
This IPO
₹121.03 Cr23.5725.51%17.06%7.12x+1.10%
Amanta Healthcare
Mainboard · listed 9 Sep 2025
₹126 Cr46.5910.89%3.86%82.6x+7.14%
Kronox Lab Sciences
Mainboard · listed 10 Jun 2024
₹130.15 Cr24.4725.66%22.60%117.25x+21.29%
Hexagon Nutrition
Mainboard · listed 12 Jun 2026
₹138.87 Cr15.3512.12%9.81%53.68x+7.22%
Gaudium IVF
Mainboard · listed 27 Feb 2026
₹165 Cr22.9941.71%26.96%7.27x+5.06%
Gujarat Kidney & Super Speciality
Mainboard · listed 30 Dec 2025
₹250.8 Cr61.6236.61%23.61%5.21x+5.26%
Sai Parenteral's
Mainboard · listed 2 Apr 2026
₹409 Cr72.195.09%8.93%1.08x+2.04%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹121.03 Cr total

How Anlon Healthcare plans to use the money raised, as stated in the offer document.

  1. Funding capital expenditure requirements for Proposed Expansion₹30.72 Cr
  2. Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company₹5 Cr
  3. Funding the working capital requirements of the Company₹43.15 Cr
  4. General Corporate Purposes₹27.03 Cr
  5. Issue Expenses₹15.13 Cr

About Anlon Healthcare

Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing company that makes high-purity pharmaceutical intermediates and active pharmaceutical ingredients. These products are raw materials for medicines such as tablets, capsules, ointments and syrups. They are also used in nutraceuticals, personal care and animal health products. The products are manufactured to pharmacopeia standards including IP, BP, EP, JP and USP. The company also offers custom manufacturing of complex chemicals. The IPO was a fresh issue of Rs 121.03 crore. Rs 43.15 crore was planned for working capital and Rs 30.72 crore for expansion.

Strengths

  • Profit after tax rose from Rs 5.82 crore in FY2023 to Rs 20.52 crore in FY2025.
  • The PAT margin was 17.06% and the EBITDA margin was 26.88%.
  • Net worth rose from Rs 7.37 crore on 31 March 2023 to Rs 80.42 crore on 31 March 2025.
  • The whole Rs 121.03 crore issue was fresh capital.
  • Return on equity was 40.45% and return on capital employed was 21.93%.

Risks

  • Total income fell from Rs 113.12 crore in FY2023 to Rs 66.69 crore in FY2024 before recovering to Rs 120.46 crore in FY2025, so income can swing.
  • Return on equity of 40.45% is high partly because net worth was small, at Rs 21.03 crore on 31 March 2024.
  • The P/E was 23.57 at the upper band of Rs 91, based on post-issue EPS of Rs 3.86.
  • Total borrowing was Rs 58.35 crore on 31 March 2025, and debt to equity was 0.73.
  • The company is small, with total assets of Rs 181.30 crore on 31 March 2025.
  • Rs 43.15 crore of the proceeds was for working capital.
  • Promoters held 70.26% before the issue and held 52.68% after it.

Promoters and shareholding

Punitkumar R. Rasadia, Meet Atulkumar Vachhani and Mamata Punitkumar Rasadia

Promoter holding, pre-issue
70.26%
Promoter holding, post-issue
52.68%

Registrar, lead managers and documents

Registrar

KFin Technologies Limited

040-79615565

ahl.ipo@kfintech.com

Company contact

+91 281 2562538

cs@anloncro.com

Anlon Healthcare IPO: common questions

1.When does the Anlon Healthcare IPO open and close?

The Anlon Healthcare IPO opens on 26 Aug 2025 and closes on 29 Aug 2025.

2.What is the price band of the Anlon Healthcare IPO?

The price band is ₹86 – ₹91 per share, with a lot size of 164 shares and a minimum investment of ₹14,924.

3.What is the size of the Anlon Healthcare IPO?

The issue size is ₹121.03 Cr (Fresh capital only).

4.What is the GMP of the Anlon Healthcare IPO?

The last reported grey market premium is ₹2 per share as of 29 Aug 2025, 12:00 PM IST. GMP is unofficial and changes frequently.

5.When is the Anlon Healthcare IPO allotment?

The basis of allotment is expected on 1 Sep 2025. Allotment status can be checked with the registrar, KFin Technologies Limited.

6.When will the Anlon Healthcare IPO list?

The shares listed on 3 Sep 2025 on BSE, NSE.

7.Who is the lead manager of the Anlon Healthcare IPO?

The book running lead manager is Interactive Financial Services Ltd., and the registrar is KFin Technologies Limited.

8.What will the money raised in the Anlon Healthcare IPO be used for?

As stated in the offer document, the proceeds are for: Funding capital expenditure requirements for Proposed Expansion; Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company; Funding the working capital requirements of the Company; General Corporate Purposes; Issue Expenses.

9.How can my company launch an IPO like Anlon Healthcare?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393